From professional translators, enterprises, web pages and freely available translation repositories.
lymfom och hudmaligniteter.
calcineurin inhibitors has been associated with an increased risk of developing lymphomas and skin malignancies.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
orsakat dessa hudmaligniteter.
the cases. ro
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
diagnosen av dessa hudmaligniteter är svår och kan likna ad.
an increase in numbers of patients with ctcl, relative to what would be expected.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
chmp höll med om att diagnosen av dessa hudmaligniteter är svår och kan likna ad.
the chmp agreed that the diagnosis of these skin malignancies is difficult and may mimic ad.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
chmp höll med om att dessa hudmaligniteter kan likna ad och att diagnosen av dem kan vara svår.
the chmp agreed that these skin malignancies may mimic ad and that their diagnosis can be difficult.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
när det gällde hudcancer drog chmp slutsatsen att behandling med takrolimus troligtvis inte hade orsakat dessa hudmaligniteter.
with regard to the skin cancers, the chmp concluded that treatment with tacrolimus was not likely to have caused these skin malignancies.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
benigna såväl som maligna neoplasier inklusive ebv-associerade lymfoproliferativa sjukdomar och hudmaligniteter har rapporterats i samband med takrolimusbehandling.
benign as well as malignant neoplasms including ebv-associated lymphoproliferative disorders and skin malignancies have been reported in association with tacrolimus treatment.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hos transplantationspatienter har långvarig systemisk exponering för intensiv immunsuppression efter systemisk administrering av calcineurinhämmare, associerats med en ökad risk för att utveckla lymfom och hudmaligniteter.
in transplant patients, prolonged systemic exposure to intense immunosuppression following systemic administration of calcineurin inhibitors has been associated with an increased risk of developing lymphomas and skin malignancies.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
vid kombinationsterapi med immunsupprimerande läkemedel, inklusive cellcept, finns en ökad risk för utveckling av lymfom och andra maligniteter, särskilt hudmaligniteter (se avsnitt 4.4).
patients receiving immunosuppressive regimens involving combinations of medicinal products, including cellcept, are at increased risk of developing lymphomas and other malignancies, particularly of the skin (see section 4.4).
Last Update: 2017-04-26
Usage Frequency: 6
Quality:
vid 2 år var frekvensen av icke- melanoma hudmaligniteter signifikant lägre i gruppen som övergick till rapamune i jämförelse med gruppen som fortsatte med calcineurinhämmare (1, 8% och 6, 9%).
at 2 years, the rate of non-melanoma skin malignancies was significantly lower in the rapamune conversion group as compared to the calcineurin inhibitors continuation group (1.8% and 6.9%).
Last Update: 2012-04-11
Usage Frequency: 2
Quality: